Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Project details

Israeli medical company seeks investment for its Ophthalmic project.

Project region Israel
Industry Healthcare
Total value of the target N/A
Expected target net rate of return after deducting all taxes and fees N/A
Validity period of pending order 365

CONTACT ADVISOR

  • Simon Laube

    Simon Laube

    Senior Associate, International Business Advisory

Project highlights Ophthalmic drug delivery - eye drops treatment - precilinical stage
Project description

The Israeli medical company is a joint venture, which authorizes the use of non-invasive local drug delivery technology, which is used to treat posterior ocular diseases by eye drops instead of current drug delivery methods (such as intravitreal injection). The platform technology can also be used for eye treatment. The project is currently in the preclinical stage of the development of a few candidate products. The company seeks investment for this project.

Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive